DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)

DongKook Pharmaceutical Revenue

DongKook Pharmaceutical had revenue of 223.74B KRW in the quarter ending March 31, 2025, with 13.67% growth. This brings the company's revenue in the last twelve months to 839.08B, up 12.32% year-over-year. In the year 2024, DongKook Pharmaceutical had annual revenue of 812.17B with 11.10% growth.

• Revenue (ttm): 839.08B
• Revenue Growth: +12.32%
• P/S Ratio: 0.94
• Revenue / Employee: 709.28M
• Employees: 1,183
• Market Cap: 786.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	812.17B	81.17B	11.10%
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%
Dec 31, 2020	559.10B	76.82B	15.93%